home
sign in
my orders
my e-books
my trolley
my account
contact
keyword
isbn13
author
title
| can't find it |
Tell us the title, author
and / or ISBN number
*
Any other details such as author,
ISBN, title or genre. Please be specific
What is your email address?
*
Not a valid email address
| browse books |
Textbooks
books
antiques & collectibles
architecture
art
biography & autobiography
body, mind & spirit
business & economics
comics & graphic novels
computers
cooking
crafts & hobbies
drama
education
family & relationships
fiction
foreign language study
games
gardening
health & fitness
history
house & home
humor
juvenile fiction
juvenile nonfiction
language arts & disciplines
law
literary collections
literary criticism
mathematics
medical
music
nature
non-classifiable
performing arts
pets
philosophy
photography
poetry
political science
psychology
reference
religion
science
self-help
social science
sports & recreation
study aids
technology
transportation
travel
true crime
books
| book details |
CDK4/6 inhibitors in Breast Cancer Therapy
Edited by
Pankaj Kumar Singh
, Edited by
Manish K. Chourasia
, Edited by
Neelesh Kumar Mehra
, Edited by
Gowthamarajan Kuppusamy
| on special |
normal price: R 7 592.95
Price: R 7 212.95
| add to trolley |
processing...
| book description |
CDK4/6 inhibitors in Breast Cancer Therapy examines the pivotal role of CDK4/6 inhibition in treating hormone receptor-positive (HR+)/HER2-negative advanced breast cancer. The book highlights FDA-approved applications of these inhibitors alongside endocrine therapy and explores ongoing research into their potential as neoadjuvant treatments. It provides insights into the drug discovery and development of CDK4/6 inhibitors, covering their molecular mechanisms, pharmacology, and clinical applications. The content addresses their use in mono and adjuvant therapies, as well as challenges in targeting, while also discussing market potential and post-marketing safety issues. This book is a valuable resource for researchers and academics, enhancing understanding of CDK4/6 inhibitors' chemistry and therapeutic implications. By presenting detailed information on clinical trials and market formulations, it equips the audience with essential knowledge to navigate the complexities of targeted breast cancer therapies and contributes to advancing research in this critical area.
| product details |
Normally shipped |
Forthcoming. We are not accepting backorders for this item yet
Publisher |
Elsevier Science Publishing Co Inc
Published date |
1 Jun 2026
Language |
Format |
Paperback / softback
Pages |
330
Dimensions |
235 x 191 x 0mm (L x W x H)
Weight |
450g
ISBN |
978-0-4434-4611-5
Readership Age |
BISAC |
medical / pharmacology
| other options |
| back |
| your trolley |
To view the items in your trolley please sign in.
| sign in |
| specials |
The Order of Time
Carlo Rovelli
Paperback / softback
224 pages
was: R 295.95
now: R 265.95
Available from overseas. Usually dispatched in 3 to 6 weeks
Originally published in Italian: L'ordine del tempo (Milan: Adelphi Edizioni, 2017).
| more |
| add to trolley |
processing...
Helgoland: The Strange and Beautiful Story of Quantum Physics
Carlo Rovelli
Paperback / softback
208 pages
was: R 295.95
now: R 265.95
Available from overseas. Usually dispatched in 3 to 6 weeks
| more |
| add to trolley |
processing...
The Coming Wave: AI, Power and Our Future
Mustafa Suleyman
Paperback / softback
352 pages
was: R 295.95
now: R 265.95
Stock is usually dispatched in 6-12 days from date of order
| more |
| add to trolley |
processing...
Copyright 2025
|
terms and conditions